Rising GLP-1 costs push employers to reconsider weight loss coverage
Employee Benefit NewsTopic alignment 92
A WTW survey found weight loss drug coverage fell for the first time in three years. Here’s why employers are rethinking the benefit and what HR can do next.
Filed under
- GLP-1 cost managementmatch 92
How to measure the long-term value of GLP-1s within employer healthcare costs
HFMATopic alignment 92
Medicare Plans Rarely Cover Anti-Obesity Drugs for Other FDA-Approved Purposes
USC SchaefferTopic alignment 95
Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health”
MedCity NewsTopic alignment 86
#AHA26: Boehringer to seek approval of obesity shot, but gaining market share could be tricky
Endpoints NewsTopic alignment 86